期刊文献+

成纤维细胞生长因子与抑郁症的相关性研究进展 被引量:1

Progress of the correlation between fibroblast growth factor and depression
原文传递
导出
摘要 抑郁症是公共卫生的一个主要问题,但目前抑郁症的发病机制仍不明确。近年来研究发现多种成纤维细胞生长因子(FGF)系统成员与抑郁症存在相关性。这些信号分子可能有望成为抑郁症的诊断和预后的生物标志物,并可能为抑郁症的治疗提供新的药物靶点。因此,本文对FGF系统的某些成员与抑郁症的相关性作一综述。 Depression is a major problem in public health. However,the mechanism of the pathogenesis of depression is still unclear. Recent studies reported that a variety of fibroblast growth factor( FGF) system members are associated with depression. These signaling molecules may be expected to become biomarkers for the diagnosis and prognosis of depression,and may provide new drug targets for the treatment of depression. In the present paper,we reviewed the correlation between certain members of fibroblast growth factor system and depression.
作者 章牧荣 曹松 杨瑞 唐密密 ZHANG Mu-rong;CAO Song;YANG Rui;TANG Mi-mi(Department of Pharmacy, Xiangya Hospital, Central South University, Changsha 410008, China;Institute of Hospital Pharmacy, Central South University, Changsha 410008, China;Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China;Institute of Menial Health, The Second Xiangya Hospital of Central South University, Changsha 410011, China)
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2019年第6期590-593,共4页 The Chinese Journal of Clinical Pharmacology
基金 湖南省自然科学基金资助项目(2018JJ3834) 中南大学湘雅医院青年科研基金资助项目(2017Q13)
关键词 抑郁症 成纤维细胞生长因子受体 成纤维细胞生长因子 depression fibroblast growth factor receptor fibroblast growth factor
  • 相关文献

参考文献2

二级参考文献49

  • 1许英蕾,孙建义.成纤维细胞生长因子与其受体的研究进展[J].药物生物技术,2004,11(3):194-198. 被引量:18
  • 2Itoh N. Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease. Cell Tissue Res. 2010; 342(1 ): 1-11.
  • 3Prudovsky I, Kumar TK, Sterling S, et al. Protein-phospholipid interactions in nonclassical protein secretion: problem and methods of study. Int J Mol Sci. 2013;14(2):3734-3772.
  • 4Itoh N, Ornitz DM. Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease. J Biochem. 2011;149(2): 121-130.
  • 5Potthoff M J, Kliewer SA, Mangelsdorf DJ. Endocrine fibroblast growth factors 15/19 and 21: from feast to famine. Genes Dev. 2012;26(4):312-324.
  • 6Goetz R, Mohammadi M. Exploring mechanisms of FGF signalling through the lens of structural biology. Nat Rev Mol Cell Biol. 2013;14(3):166-180.
  • 7Angelin B, Larsson TE, Rudling M. Circulating fibroblast growth factors as metabolic regulators-a critical appraisal. Cell Metab. 2012; 16(6):693-705.
  • 8Ding X, Boney-Montoya J, Owen BM, et al. betaKIoth is required for fibroblast growth factor 21 effects on growth and metabolism. Cell Metab. 2012;16(3): 387-393.
  • 9Wu X, Ge H, Lemon B, et al. FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation. J Biol Chem. 2010;285(8):5165-5170.
  • 10Gattineni J, Twombley K, Goetz R, Mohammadi M, Baum M. Regulation of serum 1, 25(OH)2 vitamin D3 levels by fibroblast growth factor 23 is mediated by FGF receptors 3 and 4. Am J Physiol Renal Physiol. 2011;301(2):F371-F377.

共引文献28

同被引文献20

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部